Found: 14
Select item for more details and to access through your institution.
Editorial: Peptidases as a therapeutic target in anti-cancer management.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1394018
- By:
- Publication type:
- Article
Cathepsin V regulates cell cycle progression and histone stability in the nucleus of breast cancer cells.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1271435
- By:
- Publication type:
- Article
USP17 is required for peripheral trafficking of lysosomes.
- Published in:
- EMBO Reports, 2022, v. 23, n. 4, p. 1, doi. 10.15252/embr.202051932
- By:
- Publication type:
- Article
Trafficking of Full-Length and N-Terminally Truncated Cathepsin B in Human Colorectal Carcinoma Cells.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 24, p. 11936, doi. 10.3390/app112411936
- By:
- Publication type:
- Article
Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9140, doi. 10.3390/ijms21239140
- By:
- Publication type:
- Article
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/3980273
- By:
- Publication type:
- Article
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
- Published in:
- Cell Communication & Signaling, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12964-018-0291-5
- By:
- Publication type:
- Article
Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages.
- Published in:
- Particle & Fibre Toxicology, 2016, p. 1, doi. 10.1186/s12989-016-0129-5
- By:
- Publication type:
- Article
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development.
- Published in:
- Molecular Cancer, 2016, v. 15, p. 1, doi. 10.1186/s12943-016-0513-7
- By:
- Publication type:
- Article
Cathepsin S: therapeutic, diagnostic, and prognostic potential.
- Published in:
- Biological Chemistry, 2015, v. 396, n. 8, p. 867, doi. 10.1515/hsz-2015-0114
- By:
- Publication type:
- Article
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 9, p. 2102, doi. 10.1002/ijc.28238
- By:
- Publication type:
- Article
Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012543
- By:
- Publication type:
- Article
Inhibition of cathepsin L-like proteases by cathepsin V propeptide.
- Published in:
- Biological Chemistry, 2007, v. 388, n. 5, p. 541, doi. 10.1515/BC.2007.053
- By:
- Publication type:
- Article